Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP).

Journal of the Medical Association of Thailand = Chotmaihet thangphaet

Volumn 94 Suppl 3, Issue , 2011, Pages

  Wutthiworawong, Benjawan ^a   Thitiratsanont, Usa ^b   Saovaprut, Chairat ^b   Subhangkasen, Irene ^b   Geyuraphun, Bungornrat ^b   Ampornprut, Atchara ^b   Phumongkutchai, Jinda ^b   Tephusdinnaayuthaya, Sunisa ^b  

^a QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY;

ARTICLE; DIODE LASER; FEMALE; FOLLOW UP; GESTATIONAL AGE; HOSPITAL; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; LASER COAGULATION; LOW BIRTH WEIGHT; MALE; MULTIMODALITY CANCER THERAPY; NEWBORN; PREMATURITY; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HOSPITALS, PEDIATRIC; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INTRAVITREAL INJECTIONS; LASER COAGULATION; LASERS, SEMICONDUCTOR; MALE; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84856316155     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)